Frailty is common in SLE and independently identifies patients at higher risk of adverse outcomes. Standardized definitions and longitudinal studies are needed to support risk stratification and targeted interventions.
Vértiz et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: